Wegovy Singapore

Semaglutide 2.4mg Weekly Injection for Weight Loss in Singapore

Book an Appointment
Ultimate Guide to Doctor-Prescribed

Weight Loss Medications in Singapore

Table Of Content :

Table of Contents
Primary Item (H2)

What Is the Semaglutide 2.4mg Weekly Injection and How Does It Work?

The semaglutide 2.4mg weekly injection is a prescription medication designed specifically for weight management. It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking a natural hormone that regulates appetite, slows gastric emptying, and improves satiety.
Unlike the lower-dose versions of semaglutide used for diabetes management, the 2.4mg strength has been approved for the treatment of obesity. By providing a higher weekly dose, it delivers stronger appetite suppression and more consistent weight loss outcomes in patients who have not achieved sufficient results through diet and exercise alone.
GLP-1 Pathway and Appetite Regulation
Semaglutide works by activating the glucagon-like peptide-1 (GLP-1) receptor in the body. This pathway reduces hunger signals in the brain, slows down stomach emptying, and enhances feelings of fullness. Together, these effects make it easier for patients to eat less and maintain a calorie deficit.
Why the 2.4mg Strength Is Different From Diabetes Injections
Lower-dose semaglutide injections, such as those prescribed for type 2 diabetes, usually range from 0.25mg to 1mg weekly. The 2.4mg strength, however, is specifically studied and approved for weight loss, with clinical trials showing significantly greater results in body weight reduction compared to the lower-dose versions.
Benefits Beyond Weight Loss
In addition to reducing body weight, semaglutide 2.4mg has been shown to improve several markers of metabolic health. Patients in clinical studies experienced improvements in blood sugar control, reduced waist circumference, lower cholesterol levels, and reduced cardiovascular risks. These added benefits make the treatment valuable not only for weight reduction but also for overall long-term health.

Summary

Wegovy is a once-weekly prescription GLP-1 injection containing semaglutide 2.4 mg, designed specifically for medical weight management in adults with obesity or overweight with weight-related health conditions. It works by mimicking the natural GLP-1 hormone, which reduces appetite, increases fullness, slows gastric emptying, and helps patients maintain a calorie deficit for sustained weight loss. It is currently one of the highest-dose and most effective semaglutide treatments available for weight loss.

  • Wegovy contains semaglutide 2.4 mg. This is a higher-dose formulation specifically approved for obesity treatment rather than diabetes management.
  • Works via GLP-1 receptor activation. It reduces hunger signals in the brain, slows digestion, and increases satiety after meals.
  • Once-weekly injection. Administered using a prefilled pen for convenience and consistent dosing.
  • Higher dose = stronger weight loss outcomes. Clinical trials show significantly greater weight reduction compared to lower-dose semaglutide used for diabetes.
  • Clinically proven results. STEP trials report average weight loss of around 10–15% of body weight over ~68 weeks when combined with lifestyle changes.
  • Dose is gradually increased. Patients do not start at 2.4 mg; dosing is slowly escalated from lower doses to reduce side effects and improve tolerance.
  • Supports metabolic health. Improvements may include blood sugar control, cholesterol reduction, and reduced cardiovascular risk markers.
  • Long-term treatment may be needed. Stopping the medication often leads to partial weight regain, highlighting obesity as a chronic condition.

Clinical Studies on Semaglutide 2.4mg for Weight Loss

The effectiveness of the semaglutide 2.4mg weekly injection has been demonstrated in a series of large international clinical trials known as the STEP programme. These studies involved thousands of patients across different backgrounds and medical conditions, making them one of the most comprehensive sets of weight loss data available for any prescription medication to date.
The STEP 1 trial studied adults without diabetes who were overweight or obese. Patients receiving semaglutide 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to just 2.4% in the placebo group. Many participants also reported improved quality of life, better energy levels, and reduced food cravings.
In the STEP 2 trial, patients with type 2 diabetes achieved an average weight loss of 9.6% of body weight, compared to 3.4% with placebo. While results were slightly lower than in patients without diabetes, significant improvements were seen in blood sugar control, HbA1c levels, and other metabolic health markers.
The STEP 3 trial assessed the effects of combining intensive lifestyle intervention with semaglutide 2.4mg. Patients achieved an average weight loss of 16% of body weight, highlighting the strong synergy between medical therapy and healthy lifestyle changes.
The STEP 4 trial focused on patients who had already lost weight with semaglutide 2.4mg. Those who continued treatment maintained their weight loss, while those who switched to placebo regained much of the lost weight. This highlights the importance of ongoing treatment and medical supervision for sustained results.

Who Is Suitable for the 2.4mg Weekly Injection in Singapore

The semaglutide 2.4mg weekly injection is prescribed only after a full medical consultation. Suitability depends on BMI, health conditions, and long-term weight management goals. In Singapore, doctors follow international guidelines to determine whether patients qualify for this treatment.

This higher-dose weekly injection is generally considered for:

  • Patients with a BMI of 30 or higher.
  • Patients with a BMI of 27 or higher who also have weight-related conditions such as type 2 diabetes, high blood pressure, or high cholesterol.

These criteria are based on global standards that balance the benefits of treatment against potential risks.

Patients who may benefit most include those who:

  • Struggle with appetite control despite lifestyle efforts.
  • Have not achieved sufficient results with oral semaglutide tablets or lower-dose weekly semaglutide injections (0.25mg to 1mg).
  • Prefer the convenience of a once-weekly injection compared to daily dosing.
  • Seek both significant weight reduction and improvements in overall metabolic health.

This treatment is not suitable for everyone. It is not prescribed to:

  • Patients who are pregnant, breastfeeding, or planning pregnancy.
  • Individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2).
  • Patients with severe gastrointestinal conditions such as gastroparesis.
Although the semaglutide 2.4mg weekly injection has strong evidence supporting its effectiveness, it is a potent medication that requires close medical monitoring. At Edwin Lim Medical Aesthetic Clinic, Dr Edwin and our doctors carefully review medical history, BMI, and treatment goals before prescribing. This ensures patients receive a safe, tailored plan that maximises results while minimising risks.

Dosage and Treatment Plan for the 2.4mg Weekly Injection in Singapore

The semaglutide 2.4mg weekly injection is given as a once-weekly self-administered pen. To ensure safety and tolerability, patients do not begin at the full 2.4mg dose immediately. Instead, the treatment follows a structured titration plan, starting at a lower dose and gradually increasing until the maintenance dose is reached.
Weekly Injection Schedule
The injection is administered once per week, on the same day each week, with or without food. 

Read moreless

Patients are trained by our doctors on how to use the pen correctly, rotate injection sites, and manage dosing schedules for consistent results.
Dose Escalation for Tolerability
To reduce side effects, patients typically start at 0.25mg per week, then progress...

Read moreless

progress through 0.5mg, 1mg, and 1.7mg before reaching the target maintenance dose of 2.4mg weekly. This escalation usually takes several months and allows the body to adapt gradually, improving comfort and treatment adherence.

It is important to note that not every patient needs to reach the full 2.4mg dose. If appetite suppression and weight loss are satisfactory at an intermediate dose such as 1.7mg, treatment may be continued at that level. The goal is to find the lowest effective dose that balances results with tolerability.
Doctor Monitoring and Adjustments
At Edwin Lim Medical Aesthetic Clinic, Dr Edwin and our doctors

Read moreless

, Dr Edwin and our doctors supervise the entire treatment process. Regular follow-ups allow adjustments to be made if side effects occur or if a slower escalation is needed. This personalised approach ensures patients achieve safe, steady progress and long-term weight management success.

Semaglutide 2.4mg Weight Loss Results in Singapore

The semaglutide 2.4mg weekly injection has been studied extensively in clinical trials and is now widely used in Singapore for medical weight management. Results vary between individuals, but both research data and real-world experience show consistent and meaningful reductions in body weight when the treatment is combined with lifestyle changes and regular medical follow-up.
Results at 3, 6, and 12 Months

Read moreless

In the first three months, most patients notice a reduction in appetite and steady weight loss. By six months, clinical studies such as the STEP 1 trial have shown average reductions of 7 to 12 percent of body weight, depending on lifestyle adherence and medical profile.
After 12 months of treatment, patients in these studies lost an average of 10 to 15 percent of their body weight, making this one of the most effective doctor-prescribed options currently available.
Improvements in Metabolic Health

Read moreless

Beyond weight loss, the semaglutide 2.4mg weekly injection also supports overall health. Patients in clinical studies experienced improvements in blood sugar control, reductions in waist circumference, lower cholesterol levels, and decreased blood pressure. These benefits are especially important for individuals with metabolic conditions such as prediabetes or hypertension.
Recent large-scale cardiovascular trials also demonstrated that semaglutide 2.4mg reduced the risk of major adverse cardiovascular events (including heart attack and stroke) in patients with obesity and established heart disease. This finding highlights that the treatment provides not only weight reduction but also long-term protection for overall health.
Long-Term Maintenance of Results

Read moreless

Sustained treatment is often necessary to maintain results. Studies show that patients who continue with the semaglutide 2.4mg injection are able to keep off most of the weight they lose, while those who discontinue may experience gradual regain.
At Edwin Lim Medical Aesthetic Clinic, Dr Edwin and our doctors provide structured maintenance plans to help patients preserve their progress through a combination of continued medical therapy, lifestyle guidance, and regular monitoring.

Side Effects and Safety Considerations of the 2.4mg Weekly Injection

The semaglutide 2.4mg weekly injection is a prescription medication and, like all treatments, may cause side effects. Most are mild and temporary, especially during the dose escalation phase, but proper medical supervision is essential to ensure safety throughout treatment.
Common Digestive Side Effects
The most frequently reported side effects include nausea, bloating, diarrhoea, constipation

Read moreless

, and abdominal discomfort. These symptoms usually occur during the first few weeks of dose escalation and often improve as the body adjusts. Eating smaller, balanced meals can also help reduce digestive discomfort.
Injection Site Reactions
Some patients may notice mild redness, swelling, or tenderness at the injection site. These

Read moreless

These reactions are typically short-lived and can be reduced by rotating injection sites each week.
Rare but Serious Risks
Although uncommon, serious side effects have been reported. These may include pancreatitis, gallbladder

Read moreless

issues, or thyroid-related risks in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2). This is why patient selection and monitoring are critical before and during treatment.
Why Doctor Supervision Is Essential
The 2.4mg weekly injection is a potent

Read moreless

medication that should never be used without prescription and medical oversight. At Edwin Lim Medical Aesthetic Clinic, Dr Edwin and our doctors review each patient’s medical history, explain what side effects to look out for, and provide ongoing support. Regular follow-ups allow early adjustments to improve comfort and maintain safety throughout the weight loss journey.

Cost of the 2.4mg Weekly Injection in Singapore

The cost of the semaglutide 2.4mg weekly injection varies depending on treatment stage and prescribed dose. In Singapore, patients can expect prices to range between $598 and $798 per pen before prevailing government taxes.
Each pen provides four prefilled doses, which equals 4 weeks of treatment at the prescribed strength. Pens are manufactured in fixed doses such as 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg. Patients will start with lower-dose pens during the titration phase and gradually move to higher-dose pens if tolerated.
Monthly cost varies depending on which pen is being used. Lower-dose pens during the titration phase are priced cheaper but may not deliver the same degree of appetite suppression as the higher-dose pens.

In other words, the monthly cost depends on the prescribed strength, with maintenance doses such as 1.7mg or 2.4mg typically costing more but being more effective for long-term weight reduction.
At Edwin Lim Medical Aesthetic Clinic, Dr Edwin and our doctors guide patients through the entire treatment journey, from dose escalation to long-term maintenance. The cost of care reflects not only the medication but also professional supervision, ensuring patients achieve safe, effective, and sustained weight loss.

Semaglutide 2.4mg Weekly Injection and Other Weight Loss Medications in Singapore

In Singapore, several doctor-prescribed weight loss injections and tablets are available, each with different mechanisms and results. The semaglutide 2.4mg weekly injection is one of the most effective treatments, but it is important to understand how it fits within the broader range of options.

By reviewing how it relates to lower-dose weekly injections, oral tablets, daily injectables, and newer dual-pathway therapies, patients can make more informed choices with medical guidance.
Lower-dose weekly semaglutide injections, typically ranging from 0.25mg to 1mg, are usually prescribed for type 2 diabetes management. While they may provide some degree of weight reduction, the 2.4mg weekly strength has been specifically studied for obesity treatment and consistently shows greater body weight loss.

Patients who require stronger appetite control and higher percentage reductions are often better suited to the 2.4mg strength.
Oral semaglutide tablets provide a needle-free option for patients who prefer tablets over injections. Clinical studies demonstrate meaningful weight loss of 4–6kg over several months, though results are generally less than those achieved with weekly injections.

Oral tablets may be an appropriate choice for needle-averse patients or those who prioritise convenience, but patients seeking maximum weight reduction may achieve stronger outcomes with the 2.4mg weekly injection.
Daily GLP-1 receptor agonist injections were the first in this medication class to be approved for weight management. They remain effective, with average weight loss in the range of 5–10% of body weight over a year.

However, the daily injection schedule is less convenient for many patients. The 2.4mg once-weekly injection offers both stronger clinical results and improved convenience, supporting better long-term adherence.
Dual GLP-1 and GIP weekly injections represent the latest advance in weight loss medications. Clinical research shows average reductions of 15–20% of total body weight, which may exceed single-pathway GLP-1 therapies.

While this dual-pathway treatment is highly effective, it may not be suitable for all patients. The choice between single-pathway and dual-pathway therapy depends on each patient’s medical background, tolerability, and long-term goals as assessed by their doctor.

How Semaglutide 2.4mg Weekly Injection Differs From Other Weight Loss Approaches

While the semaglutide 2.4mg weekly injection is one of the most effective doctor-prescribed weight management treatments available in Singapore, it is only part of the wider landscape of weight loss options. Many patients may wonder how this medical treatment compares with diet, exercise, or non-prescription products.
Healthy eating and regular physical activity remain the foundation of weight management. However, many patients reach a plateau despite consistent lifestyle efforts. The semaglutide 2.4mg injection works on appetite regulation and satiety hormones, helping patients overcome biological barriers that diet and exercise alone may not address.
Over-the-counter slimming supplements are widely marketed in Singapore but are not clinically proven to deliver sustained weight loss. In contrast, semaglutide 2.4mg has been extensively studied in large international clinical trials, demonstrating consistent results and additional health benefits beyond weight reduction.
Bariatric surgery is an option for severe obesity, but it is invasive and requires permanent changes to the digestive system. The semaglutide 2.4mg injection provides a non-surgical, less invasive alternative, offering meaningful weight loss for patients who may not be ready or suitable for surgery.

Long-Term Use and Maintenance After the 2.4mg Weekly Injection

The semaglutide 2.4mg weekly injection has been shown to deliver significant weight loss, but long-term management is equally important. Research and clinical practice confirm that obesity is a chronic condition, and patients often need continued treatment or structured maintenance plans to preserve results.
How Long Patients Usually Stay on the 2.4mg Weekly Injection

Read moreless

Many patients use the injection for at least 6 to 12 months to achieve meaningful reductions in body weight. Some continue for several years under doctor supervision, especially if ongoing appetite control and metabolic benefits are needed. The duration of treatment is personalised, depending on progress and overall health.
What Happens After Stopping the 2.4mg Weekly Injection

Read moreless

Clinical studies show that patients who discontinue treatment tend to regain some of the weight they lost, with research suggesting that up to two-thirds of prior reductions may return within a year. This highlights the importance of either continuing therapy or transitioning into a structured maintenance plan guided by a doctor.
Doctor-Guided Maintenance Strategies

Read moreless

At Edwin Lim Medical Aesthetic Clinic, Dr Edwin and our doctors support patients with long-term strategies that may include:

  • Continuing the 2.4mg injection at maintenance dose if suitable.
  • Transitioning to a lower dose or alternative doctor-prescribed weight loss medication.
  • Lifestyle guidance to reinforce sustainable nutrition, exercise, sleep, and stress management habits.

These personalised strategies help patients maintain results, reduce the risk of weight regain, and continue improving overall health even after active treatment is tapered.

Typical Patient Experience With the 2.4mg Weekly Injection in Singapore

Patients starting the semaglutide 2.4mg weekly injection often want to know what to expect during treatment. While experiences vary depending on medical history, lifestyle, and dosing stage, most patients notice predictable changes in appetite, food intake, and weight over time.
During the first month at the lowest doses, many patients report a noticeable reduction in appetite and smaller portion sizes. Some may experience mild digestive side effects such as nausea or bloating, which typically improve as the body adjusts. This early stage often builds momentum for continued progress.
By three months, steady weight reduction is usually visible. Clinical research shows average weight loss of 7 to 12 percent of body weight at six months. Patients often describe feeling more in control of food choices and less prone to overeating, which supports sustained progress.
After one year, patients in clinical trials achieved an average of 10 to 15 percent weight loss, with additional benefits such as reduced waist circumference and improved blood sugar control. Many also report better energy levels, enhanced mobility, and greater confidence in their health.
At Edwin Lim Medical Aesthetic Clinic, Dr Edwin and our doctors schedule regular follow-ups to review progress, adjust dosage if needed, and provide ongoing lifestyle guidance. This medical support ensures patients stay on track, manage side effects effectively, and achieve the best possible long-term results.

Lifestyle Support While on the 2.4mg Weekly Injection in Singapore

The semaglutide 2.4mg weekly injection is most effective when combined with healthy lifestyle changes. While the medication reduces appetite and supports calorie control, long-term success depends on sustainable habits in nutrition, exercise, sleep, and stress management.
Many patients find it easier to eat smaller portions once their appetite is reduced. Focusing on balanced meals with lean proteins, whole grains, fruits, and vegetables helps maintain steady progress. Avoiding high-calorie, processed foods supports the medication’s effects and improves overall health.
Physical activity helps preserve muscle mass, maintain metabolism, and enhance weight reduction. Even moderate exercise, such as walking, cycling, or strength training, can improve outcomes. Patients who combine the injection with regular exercise often achieve greater improvements in body composition and fitness.
Poor sleep and high stress can disrupt appetite hormones, making weight loss more difficult. Addressing these factors by improving sleep hygiene and adopting stress management strategies, such as mindfulness or relaxation techniques, complements the effects of the 2.4mg weekly injection.
The goal of treatment is not just initial weight loss but long-term maintenance. Patients who adopt consistent nutrition, activity, sleep, and stress management practices are more likely to sustain results even after treatment is tapered. At Edwin Lim Medical Aesthetic Clinic, Dr Edwin and our doctors provide ongoing support to help patients build these lasting habits.

Semaglutide 2.4mg Weekly Injection in Singapore – Key Takeaways

The semaglutide 2.4mg weekly injection is a doctor-prescribed treatment designed for effective, medically supervised weight loss. It is well-studied in international clinical trials and is available in Singapore only under professional care.
Proven Effectiveness

Read moreless

Clinical studies such as the STEP programme show average reductions of 10–15% of body weight over 68 weeks, making it one of the most effective non-surgical options for weight management.
Long-Term Success

Read moreless

Sustained results depend on combining treatment with lifestyle changes. Doctor follow-ups, structured nutrition, physical activity, sleep, and stress management are essential for maintaining weight loss and overall health.
Doctor-Guided Safety

Read moreless

Not everyone is suitable for semaglutide 2.4mg. Medical screening is essential to rule out contraindications and ensure side effects are managed safely through dose escalation and ongoing monitoring.
Convenience and Dosing

Read moreless

The once-weekly injection is titrated from lower doses up to 2.4mg. Each pen contains four prefilled doses, making it a simple and convenient treatment for patients in Singapore.
Cost and Value

Read moreless

The cost of treatment in Singapore typically ranges from $598 to $798 per pen before prevailing government taxes. While the medication itself is a key part of the investment, value also comes from ongoing medical guidance and lifestyle support.
Proven Effectiveness

Read moreless

Clinical studies such as the STEP programme show average reductions of 10–15% of body weight over 68 weeks, making it one of the most effective non-surgical options for weight management.
Convenience and Dosing

Read moreless

The once-weekly injection is titrated from lower doses up to 2.4mg. Each pen contains four prefilled doses, making it a simple and convenient treatment for patients in Singapore.
Cost and Value

Read moreless

The cost of treatment in Singapore typically ranges from $598 to $798 per pen before prevailing government taxes. While the medication itself is a key part of the investment, value also comes from ongoing medical guidance and lifestyle support.
Long-Term Success

Read moreless

Sustained results depend on combining treatment with lifestyle changes. Doctor follow-ups, structured nutrition, physical activity, sleep, and stress management are essential for maintaining weight loss and overall health.
Doctor-Guided Safety

Read moreless

Not everyone is suitable for semaglutide 2.4mg. Medical screening is essential to rule out contraindications and ensure side effects are managed safely through dose escalation and ongoing monitoring.

Frequently Asked Questions
About Semaglutide 2.4mg Weekly Injection in Singapore

The semaglutide 2.4mg weekly injection, also known as Wegovy, has been shown in STEP clinical trials to produce average weight reductions of 10–15% over 68 weeks. Some patients in Singapore may experience even greater results depending on their BMI, lifestyle, and medical background. Compared to lower-dose semaglutide injections such as Ozempic, the 2.4mg strength delivers more consistent weight loss.
Most patients use semaglutide 2.4mg for at least 6 to 12 months, while some continue longer for maintenance. Studies show that patients who stop Wegovy may regain up to two-thirds of their lost weight within a year. In such cases, doctors may recommend transitioning to a maintenance plan or considering alternatives like Mounjaro for stronger dual-pathway appetite control.
The most common side effects of Wegovy include nausea, bloating, diarrhoea, constipation, and stomach discomfort, particularly during dose escalation. These effects often improve as the body adjusts. Rare risks such as pancreatitis or gallbladder issues require medical monitoring. Oral semaglutide (Rybelsus) and dual GLP-1/GIP therapies like Mounjaro share similar digestive side effects.
Wegovy is generally prescribed for patients with a BMI of 30 or above, or for those with a BMI of 27 or above who also have weight-related conditions such as diabetes or hypertension. Suitability must be assessed by a doctor, who may also discuss alternatives like lower-dose semaglutide injections or oral semaglutide tablets (Rybelsus) depending on the patient’s needs.
In Singapore, Wegovy typically costs between $598 and $798 per pen before prevailing government taxes. Each pen provides four weekly doses. Monthly costs depend on the prescribed strength, with higher doses such as 1.7mg or 2.4mg being more effective but also more expensive.
Beyond weight loss, Wegovy has been shown to improve blood sugar control, lower cholesterol, reduce waist circumference, and lower blood pressure. Recent clinical trials also demonstrated that semaglutide 2.4mg reduces the risk of major cardiovascular events such as heart attack and stroke, making it a valuable long-term health intervention.
Some patients in Singapore transition from lower-dose semaglutide injections (Ozempic) or oral semaglutide (Rybelsus) to the 2.4mg weekly injection when stronger results are needed. Others may move from or consider switching to dual GLP-1/GIP therapy such as Mounjaro if further weight reduction is required. All changes should only be made under medical supervision.
Long-term studies show that Wegovy is generally safe when used under medical supervision. Treatment duration depends on the patient’s goals and response. Doctors may recommend continuing indefinitely for patients who benefit from ongoing appetite control and metabolic improvements.
Wegovy is not recommended during pregnancy or breastfeeding. Patients planning pregnancy should discontinue use well in advance. Doctors may advise safer alternatives or focus on lifestyle measures until it is safe to resume medication.
Clinical data shows that both men and women benefit from Wegovy with similar effectiveness. Differences in results are usually related to individual health factors such as baseline BMI, metabolism, and adherence to lifestyle recommendations rather than gender itself.

What to Expect During Your First Consultation in Singapore

Before starting the semaglutide 2.4mg weekly injection, patients in Singapore undergo a detailed consultation with a doctor. This process ensures that treatment is safe, medically appropriate, and tailored to each individual’s needs.
Medical History and Eligibility Assessment
During the consultation, our doctors review medical history, BMI, and weight-related conditions such as diabetes, high blood pressure, or cholesterol levels. This helps confirm whether semaglutide 2.4mg meets the international criteria for prescribing and rules out any contraindications.
Setting Realistic Weight Loss Goals
Every patient’s journey is different. Dr Edwin and our doctors discuss individual goals, whether that means reducing overall body weight, improving metabolic health, or addressing specific conditions. This step helps align expectations with what clinical studies show to be achievable.

Explanation of Treatment Plan and Dosage Schedule
Our doctors explain the stepwise escalation from 0.25mg up to the maintenance dose of 2.4mg weekly. Patients learn how the titration schedule improves tolerability, what to expect at each stage, and how side effects can be managed effectively.
Lifestyle and Supportive Care Discussion
The consultation also covers lifestyle factors that can enhance treatment results. Nutrition, exercise, sleep, and stress management are reviewed so patients understand how to combine the semaglutide 2.4mg weekly injection with long-term health habits.

Get Professional Advice
Begin Your Doctor-Supervised Weight Loss Journey Today

The semaglutide 2.4mg weekly injection has been extensively studied and proven to support meaningful weight loss when used under proper medical supervision. While treatment results vary, long-term success is best achieved with a doctor who can guide you through safe dose adjustments, manage side effects, and provide lifestyle support. If you are ready to take control of your health, the first step is a personalised consultation.

Schedule Your Consultation With Dr Edwin and Our Doctors

Our clinic provides medically guided weight loss programmes using treatments such as the semaglutide 2.4mg weekly injection. During your consultation, Dr Edwin and our doctors will assess your goals, determine suitability, and design a safe, effective plan for long-term results.
Book a Consultation Here

Take the First Step Towards Safe and Sustainable Weight Loss

Oral semaglutide tablets provide a needle-free option for patients in Singapore who want medical support in their weight loss journey. With doctor supervision, structured dosing, and lifestyle guidance, this treatment can help you achieve steady, lasting results.

To learn if oral semaglutide is suitable for you, book a consultation with Dr Edwin Lim and our doctors today.
Book a Consultation
Personalised Medical Care

Safe and Effective Weight Management

Achieve Your Health Goals with Dr Edwin Lim

#02-12/13 Changi City Point
#05-51, Lucky Plaza (By Appointment Only)

    Menu
    close
    © 2026 Weight Loss Clinic by Edwin Lim Medical Aesthetic Clinic
    crossmenuchevron-downarrow-down